Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Restricted Cash and Investments by Year
Restricted Cash and Investments ($M)
Elevance Health Restricted Cash and Investments: $348M in FY2025, down 14.9% from a year earlier.
Latest, FY2025
348
Period ended Dec 31, 2025
Change on a year earlier
-14.9%
409 in FY2024
History
11 years
Since FY2015
Sources
2
Documents cited below
Where the FY2025 figure comes from
“us-gaap:RestrictedCashAndInvestmentsCurrent (2025-12-31): 348,000,000.00”
Source: ELV 10-Q (XBRL us-gaap:RestrictedCashAndInvestmentsCurrent) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Elevance Health Restricted Cash and Investments ($M), annual FY2015–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-restricted-cash-and-investments
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.